Filter News
Area of Research
- (-) National Security (13)
- (-) Nuclear Science and Technology (9)
- Advanced Manufacturing (4)
- Biology and Environment (40)
- Clean Energy (92)
- Climate and Environmental Systems (4)
- Computational Engineering (1)
- Computer Science (2)
- Fusion and Fission (3)
- Isotope Development and Production (1)
- Isotopes (10)
- Materials (55)
- Materials for Computing (13)
- Mathematics (1)
- Neutron Science (13)
- Quantum information Science (2)
- Supercomputing (24)
- Transportation Systems (2)
News Type
News Topics
- (-) Cybersecurity (10)
- (-) Environment (2)
- (-) Isotopes (3)
- (-) Molten Salt (3)
- (-) Space Exploration (4)
- (-) Transportation (2)
- 3-D Printing/Advanced Manufacturing (3)
- Advanced Reactors (7)
- Artificial Intelligence (6)
- Big Data (2)
- Bioenergy (2)
- Biology (2)
- Biomedical (3)
- Chemical Sciences (2)
- Climate Change (1)
- Computer Science (11)
- Coronavirus (1)
- Decarbonization (1)
- Energy Storage (2)
- Exascale Computing (1)
- Frontier (1)
- Fusion (3)
- Grid (3)
- High-Performance Computing (1)
- Machine Learning (4)
- Materials (1)
- Materials Science (2)
- National Security (11)
- Neutron Science (5)
- Nuclear Energy (19)
- Partnerships (4)
- Physics (2)
- Security (6)
- Summit (1)
- Sustainable Energy (3)
- Transformational Challenge Reactor (1)
Media Contacts
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.
With the production of 50 grams of plutonium-238, researchers at the Department of Energy’s Oak Ridge National Laboratory have restored a U.S. capability dormant for nearly 30 years and set the course to provide power for NASA and other missions.